Clinical Trials Browser

Phase 2 × OTHER × Li-Fraumeni Syndrome × Clear all

NCT06088030 2024-01-03

Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer

Phase 2 Recruiting

Neoplasms, Li-Fraumeni Syndrome